Detalles de la búsqueda
1.
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.
Eur J Haematol
; 112(4): 641-649, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164819
2.
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
J Antimicrob Chemother
; 78(8): 1813-1826, 2023 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37311136
3.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678031
4.
Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.
Eur J Haematol
; 111(6): 914-921, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37705250
5.
Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry.
Infection
; 51(4): 1153-1159, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37016194
6.
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.
Transfus Med Hemother
; 50(6): 475-490, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089497
7.
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study.
Transfus Med Hemother
; 50(5): 403-416, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37899991
8.
Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study.
Ann Hematol
; 101(10): 2317-2324, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35978182
9.
Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus.
Ann Hematol
; 101(3): 491-511, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994811
10.
Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Ann Hematol
; 100(2): 321-336, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079221
11.
Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Mycoses
; 63(7): 653-682, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236989
12.
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.
Ann Hematol
; 98(7): 1755-1763, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993417
13.
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO).
Mycoses
; 61(11): 796-813, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30098069
14.
Central venous catheter-related bloodstream infections in patients with haematological malignancies during the SARS-CoV-2 pandemic.
Br J Haematol
; 199(4): e16-e20, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36017820
15.
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.
Br J Haematol
; 176(5): 770-782, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27983764
16.
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE.
Eur J Haematol
; 99(1): 42-50, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370401
17.
Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
Mol Carcinog
; 55(12): 1927-1939, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27023728
18.
Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective.
Crit Rev Microbiol
; 42(1): 1-16, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-24495097
19.
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.
BMC Cancer
; 16: 290, 2016 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114074
20.
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.
Ann Hematol
; 95(9): 1435-55, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27339055